Aresa joined alternative market
Copenhagen - The Danish biotech company Aresa A/S has joined the newly formed First North Stock Exchange in February - as first biotech company and second company on the alternative marketplace in Denmark. The offering of shares was met with interest from private as well as institutional investors: In total, Aresa received Euro7.3 million and got some 800 new shareholders.
“Aresa is undergoing rapid development, and with the admission to First North we now have the best framework for establishing the financial basis to place our products on the market,” said CEO Jarne Elleholm.
Aresa was established in 2001 and derives its scientific basis from the Institute of Molecular Biology and Physiology at the University of Copenhagen. The company has developed two plant technologies called BioSensor and BioPharma based on the plant Arabidopsis thaliana.
BioSensor is a patented invention covering a controlled colour change in plants within 3-5 weeks thereby localising mines and unexploded ammunition in the ground. The invention may speed the removal of landmines and unexploded ordnance (UXO) in cultivatable areas.
Biopharma, however, is a patented method of producing and screening antibodies produced in transgenic plants.